Sanofi Completes Acquisition of Blueprint Medicines
Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint),…
Sanofi Expands Immunology Footprint with $9.1 Billion Blueprint Medicines Acquisition
Sanofi has announced an agreement to acquire Blueprint Medicines Corporation, a US-based…
Avalo Therapeutics Appoints Dr. Rita Jain to Board as Phase 2 HS Trial Advances
Avalo Therapeutics, a clinical-stage biotechnology company focused on the treatment of immune…
AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA…
AbbVie Awards Scholarships to 45 Students with Chronic Diseases
NORTH CHICAGO, Ill- AbbVie recently announced the 2024-2025 recipients of the AbbVie…
Bio-Rad Launches New StarBright Red Dyes for Immunology Research
May, 2024- Bio-Rad Laboratories announced the launch of three new StarBright™ Red…